The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)

NCT00075998 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

826

Enrollment

INDUSTRY

Sponsor class

Stopped test drug showed lack of benefit at interim analysis

Conditions

Idiopathic Pulmonary Fibrosis
Lung Disease
Pulmonary Fibrosis

Interventions

DRUG: Interferon gamma-1b ("Actimmune")

Sponsor

InterMune